Probe Scientific has been successful in its application for grant funds as part of the highly rated EU clamp study. This will result in Probe’s MicroEye® being evaluated in a number of key European centres. MicroEye® will be evaluated with a variety of different sensor and pump systems.
Despite increasing expenditure on diabetes treatment, many suffers do not achieve good glycaemic control. New drugs are in development and a key technology in their search is the euglycaemic glucose clamp technique. This method measures the effectiveness of a new anti-diabetic drug to lower blood glucose levels by stabilising a subject’s blood glucose concentration at a target level through a variable infusion of glucose. Our EU-CLAMP Project aims to develop a new generation of automated clamp device using Probe’s MicroEye platform technology. The EU-CLAMP project receives funding from the European Union’s Seventh Framework Programme.
Further information is available from the at EU-Clamp Project website at http://www.euclamp.eu.